| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |